Position in TNYA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,705
+$108 QoQ
Shares Held
2,308
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 101 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. TNYA ranks #320 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in TNYA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,705 | 2,308 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,597 | 2,308 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,967 | 2,764 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,477 | 2,764 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,688 | 2,764 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,945 | 26,220 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $49,581 | 34,673 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,597,660 | 1,345,938 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,093,348 | 1,320,435 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $15,219,958 | 2,910,126 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $8,601,393 | 2,654,751 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,126,214 | 3,186,751 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $22,037,382 | 3,754,239 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,716,843 | 3,760,296 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $5,689,256 | 2,830,476 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,063,362 | 3,125,298 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $31,128,505 | 5,529,042 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $72,941,852 | 6,192,008 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $108,464,721 | 5,723,732 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $105,386,799 | 5,103,477 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||